Browsing “Press Releases - FSHD Society”

Epicrispr Biotechnologies Doses First Patient in First-in-Human Clinical Trial of EPI-321 for Facioscapulohumeral Muscular Dystrophy

Posted on August 7th, 20258/7/25

Filed under:

Read More

Epicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study

Posted on April 25th, 20254/25/25

Filed under:

Read More

Springbok Analytics Leads MRI Innovations in Multi-Site Pediatric FSHD Clinical Study

Posted on March 21st, 20253/21/25

Filed under:

Read More

FSHD Society Strengthens Leadership with Experts in Healthcare, Biotech, and Market Access

Posted on February 26th, 20252/26/25

Filed under:

Read More

New global coalition to speed delivery of therapies for FSHD

Posted on March 26th, 20243/26/24

Filed under:

Read More